NCT00287820 Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism Status COMPLETED Phase PHASE4
NCT00275301 PET Imaging and Olanzapine Treatment in Borderline Personality Disorder Status COMPLETED Phase NA
NCT00273624 Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled Trial Status WITHDRAWN Phase PHASE3
NCT00266630 Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder Status COMPLETED Phase PHASE3
NCT00265343 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777) Status COMPLETED Phase PHASE3
NCT00260962 Olanzapine in the Treatment of Patients With Anorexia Nervosa Status COMPLETED Phase PHASE2
NCT00259272 Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine Status COMPLETED Phase PHASE3
NCT00255879 Movement Disorders Caused by Antipsychotic Drugs in Older Patients Status COMPLETED Phase PHASE1
NCT00239109 Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia. Status COMPLETED Phase PHASE4
NCT00237861 Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia Status COMPLETED Phase PHASE4
NCT00236379 A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder Status COMPLETED Phase PHASE4
NCT00222495 A Comparative Study of New Medications for Psychosis in Adolescents Status COMPLETED Phase NA
NCT00212836 Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817) Status COMPLETED Phase PHASE3
NCT00212784 Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Status COMPLETED Phase PHASE3
NCT00212771 Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846) Status COMPLETED Phase PHASE3
NCT00208819 A Comparison of Two Standard Therapies in the Management of Dementia With Agitation Status COMPLETED Phase PHASE4
NCT00202293 Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features Status COMPLETED Phase PHASE4